Safety, immunogenicity and duration of protection of the RTS,S/ASO2D malaria vaccine: One year follow-up of a randomized controlled phase I/IIb trial

Pedro Aide, John Aponte, Montse Renom, Tacilta Nhampossa, Jahit Sacarlal, Inácio Mandomando, Quique Bassat, Maria Manaca, Amanda Leach, Marc Lievens, Johan Vekemans, Marie-Claude Dubois, Christian Loucq, Ripley Ballou, Joe Cohen, Pedro Alonso

    Research output: Contribution to journalArticle

    Original languageEnglish
    Pages (from-to)1-9
    Number of pages9
    JournalPLoS One
    Volume5
    Issue number11
    Publication statusPublished - 2010

    Cite this

    Aide, P., Aponte, J., Renom, M., Nhampossa, T., Sacarlal, J., Mandomando, I., ... Alonso, P. (2010). Safety, immunogenicity and duration of protection of the RTS,S/ASO2D malaria vaccine: One year follow-up of a randomized controlled phase I/IIb trial. PLoS One, 5(11), 1-9.